Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study. - Knikman JE; de With M; Heersche N; Lopez-Yurda M; Baars A; Creemers GJ; Droogendijk HJ; Fiets E; Imholz ALT; Iersel LV; Mandigers CMPW; van de Vendel AJ; et al. (European journal of cancer (Oxford, England : 1990), 2025)